|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
|
Robotics in Manufacturing
Seeing the Light
Vision-equipped robots can help the pharmaceutical industry take full advantage of automated systems in both the factory and the laboratory, reducing human error and increasing efficiency, as Nigel Smith at TM Robotics demonstrates. |
|
|
GCC Countries
Spanning the Gulf
Ahed Ghanem at PricewaterhouseCoopers reviews the current marketplace in the Gulf Cooperation Council (GCC) countries, and points to the business culture and systems that operate in the region, which must be considered before looking to establish a local base.
|
|
|
MENA Region
Thinking Outside the Box
The Middle East and North Africa area presents a whole host of challenges to the transporter, not only including the obvious temperature management issues, but also the general infrastructure of the region, as Roland Nicholas and Karen Adams at SCA Cool Logistics discuss.
|
|
|
Packaging: Japanese Scene
Blossoming Marketplace
When it comes to contract packaging, the advantages of a full service offering are clear, and can be displayed further by the methods being employed in the Japanese market, explains Jeremy Drummond at Aesica.
|
|
|
Machinery: Workplace Ergonomics
Getting a Lift
Protecting employees from injury is vital for every manufacturer, both in terms of avoiding wasted pay and reduced manpower, not to mention potential compensation. Adiam Tewelde at TAWI AB puts forward ergonomic lifting aids as a safer and ultimately cheaper solution to keep employees from harm.
|
|
|
Eastern Europe
A Tale of Three Countries
Martin Meyer at Lodestone Management Consultants provides an analysis of the pros and cons of three major regional hubs – Hungary, Romania and Bulgaria – and compares the infrastructure of each.
|
|
|
Track and Trace
Coding Looks to the Future
Harry Thomason of the Travtec Group provides an overview of the use of coding on pharmaceutical packaging over the last 30 years, and considers how the current technology available is providing an essential service to the industry.
|
|
|
Packaging Design
In the Details
Jane Donaghey at Almac Pharma Services gives a breakdown of the major factors that come into play when designing external packaging for a pharma product, including ease of use, compliance, safety and brand awareness.
|
|
|
Logistics Management
Optimal Operations
With the logistics branch of a pharma operation becoming increasingly recognised for its value-adding potential, Johan Beukema at Buck Consultants International discusses performance optimisation methods that can be undertaken throughout the logistics process.
|
|
|
Oral Liquid Medications
Fluid Thinking
Günter Nadler, Matthias Birkhoff and Degenhard Marx at Aptar Pharma explain how over-the-counter liquid medications must encourage compliance while still providing consumers with perceived value and ease of use.
|
|
|
Parenteral Products
A Question of Use
For the delivery of biopharmaceutical formulations, multilayer plastic parenteral vials offer a stronger, more reliable format with enhanced barrier properties, as Wolfgang Dirk at Gerresheimer AG shows.
|
|
|
The End of the Line
Pushing the Envelope
The simplest of technologies can often give rise to the best solutions, as Richard Harrop explains.
|
|
|
Manufacturing: Analytical Software
Data at Work
A manufacturing intelligence platform can allow valuable comparisons between sites to be made, improving performance levels across the board. Randy Tatlock at Aegis Analytical Corp gives details of the methodologies involved.
|
|
|
Cleanrooms: Flooring Systems
Got it Covered
The management of particulate contamination is an essential task for a cleanroom manager. Eva Paraskevaides at Dycem Limited highlights the importance of selecting the right kind of flooring, and how it can even work out cheaper in the long run.
|
|
|
Drug Delivery: Particle Analysis
Size Matters
Deborah Huck at Malvern Instruments points out the importance of the correct identification and characterisation of oversized particles that must be eliminated from inhaled drug formulations before they are ready to be packaged and used.
|
|
|
Functional Excipients for Solid Dosage
Recipe for Success
Steffen Denzinger at Merck KgaA presents functional solid dose excipients as an answer to the increased demand for productivity in the face of falling drug approval rates.
|
|
|
Disposable Filling Needles
One Use, One Solution
Benedikt Knoch at RAUMEDIC AG makes a case for single-use systems in the manufacturing sphere, which not only save on cleaning costs, but also provide a ready-made, sterile solution, free from previous contamination.
|
|
|
Manufacturing Philosophies
Make it Better
Stuart Kay and Christian Dunning at Team Consulting Ltd advocate a risk-based approach to manufacturing, which assesses the level of risk in each element of the process and allows an optimal setup to be reached in terms of time, cost and safety.
|
|
|
|
Interview
Roll up, Roll up
In the run up to ICSE, InnoPack, P-MEC and BioPh, taking place from 25th to 27th October 2011 at Messe Frankfurt, Germany, Haf Cennydd, Global Brand Director for the event at UBM Live answers PMPS’ questions on how the show is run and what we can expect this year.
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center
Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020:
Italian-based Stevanato Group, a leading producer of glass primary
packaging and provider of integrated services for combination products,
and Nelson Laboratories, LLC, a global provider of lab testing and
expert advisory services signed today a partnership agreement that will
provide Extractables and Leachables testing at SG US Technology
Excellence Center in Boston, MA.
More info >> |
|
 |
White Papers |
 |
|
Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services
DrugDev
With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >> |
|
|
